All stock lists
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
89.47+0.20 (+0.22%)
Insider Score
––Not scored
RYTM Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
RYTM analyst forecast
RYTM analyst consensus
No analyst ratings in the last 3 months.
RYTM 12-month price target
$136.33+53.1% upsideaverage of 3 firms
$159.00High
$120.00Low
Best analysts covering RYTM
No firm covering RYTM has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
RYTM analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| H.C. Wainwright | — | $130.00 | +43.2% | — | 2026-10-12 | |
| RBC Capital | — | $159.00 | +81.3% | — | 2026-10-08 | |
| Deutsche Bank | — | $120.00 | +6.6% | — | 2026-08-28 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.